{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:59:28Z","timestamp":1758970768990},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The Orsiro Hybrid sirolimus-eluting stent is a newly developed third-generation drug-eluting stent, featuring a unique dual-polymer mix. An active bioabsorbable polymer delivers the anti-proliferative drug, sirolimus, via controlled release, while a passive biocompatible polymeric coating shields the metallic strut from surrounding tissue, preventing interaction. To date, the Orsiro Hybrid sirolimus-eluting stent has excelled in terms of late lumen loss at 9 months in a first-in-man single-arm trial. However, the efficacy and safety data for Orsiro Hybrid sirolimus-eluting stents in a broader population of all-comers are limited. The present study offers an angiographic and clinical comparison of the Orsiro Hybrid sirolimus-eluting stent and the Resolute Integrity zotarolimus-eluting stent in the treatment of patients with coronary artery disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods\/design<\/jats:title>\n            <jats:p>The ORIENT trial is a multicenter, randomized, open-label, parallel-arm study designed to demonstrate the non-inferiority of the Orsiro Hybrid sirolimus-eluting stent relative to the Resolute Integrity zotarolimus-eluting stent. A total of 375 patients with a spectrum of coronary artery disease will undergo prospective, random assignment to a Orsiro Hybrid sirolimus-eluting stent or Resolute Integrity zotarolimus-eluting stent (2:1 ratio), for a primary endpoint of in-stent late lumen loss at 9 months by quantitative coronary angiography. Secondary 12-month clinical endpoints are death, target lesion revascularization, target vessel revascularization, myocardial infarction, stent thrombosis and target lesion failure (a composite of cardiac death, target lesion revascularization and target vessel-related myocardial infarction).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>The ORIENT trial is the first study to date comparing the Orsiro Hybrid sirolimus-eluting stent with the Resolute Integrity zotarolimus-eluting stent for efficacy and safety in a population of all-comers with coronary artery disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>Clinicaltrials.gov <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01826552\" ext-link-type=\"uri\">NCT01826552<\/jats:ext-link>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1745-6215-14-398","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T01:00:55Z","timestamp":1384995655000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Angiographic and clinical comparison of novel Orsiro Hybrid sirolimus-eluting stents and Resolute Integrity zotarolimus-eluting stents in all-comers with coronary artery disease (ORIENT trial): study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"14","author":[{"given":"Joo Myung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Don","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Yup","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon-Hyung","family":"Doh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Man","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jang-Whan","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo-Young","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Jin","family":"Youn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,20]]},"reference":[{"key":"1566_CR1","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1056\/NEJMoa012843","volume":"346","author":"MC Morice","year":"2002","unstructured":"Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R, Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R: A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002, 346: 1773-1780. 10.1056\/NEJMoa012843.","journal-title":"N Engl J Med"},{"key":"1566_CR2","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJMoa035071","volume":"349","author":"JW Moses","year":"2003","unstructured":"Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE: Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003, 349: 1315-1323. 10.1056\/NEJMoa035071.","journal-title":"N Engl J Med"},{"key":"1566_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa032441","volume":"350","author":"GW Stone","year":"2004","unstructured":"Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME: A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004, 350: 221-231. 10.1056\/NEJMoa032441.","journal-title":"N Engl J Med"},{"key":"1566_CR4","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1056\/NEJMe1001069","volume":"362","author":"RA Lange","year":"2010","unstructured":"Lange RA, Hillis LD: Second-generation drug-eluting coronary stents. N Engl J Med. 2010, 362: 1728-1730. 10.1056\/NEJMe1001069.","journal-title":"N Engl J Med"},{"key":"1566_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1161\/CIRCINTERVENTIONS.111.967083","volume":"5","author":"T Palmerini","year":"2012","unstructured":"Palmerini T, Kirtane AJ, Serruys PW, Smits PC, Kedhi E, Kereiakes D, Sangiorgi D, Reggiani LB, Kaiser C, Kim HS, De Waha A, Ribichini F, Stone GW: Stent thrombosis with everolimus-eluting stents: meta-analysis of comparative randomized controlled trials. Circ Cardiovasc Interv. 2012, 5: 357-364. 10.1161\/CIRCINTERVENTIONS.111.967083.","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"1566_CR6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.15420\/icr.2011.6.2.142","volume":"6","author":"M Tittelbach","year":"2011","unstructured":"Tittelbach M, Diener T: Orsiro \u2013 the first hybrid drug-eluting stent, opening up a new class of drug-eluting stents for superior patient outcomes. Interv Cardiol. 2011, 6 (2): 142-144.","journal-title":"Interv Cardiol"},{"key":"1566_CR7","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.4244\/EIJV8I9A155","volume":"8","author":"M Hamon","year":"2013","unstructured":"Hamon M, Niculescu R, Deleanu D, Dorobantu M, Weissman NJ, Waksman R: Clinical and angiographic experience with a third-generation drug-eluting Orsiro stent in the treatment of single de novo coronary artery lesions (BIOFLOW-I): a prospective, first-in-man study. EuroIntervention. 2013, 8: 1006-1011. 10.4244\/EIJV8I9A155.","journal-title":"EuroIntervention"},{"key":"1566_CR8","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq172","volume":"31","author":"W Wijns","year":"2010","unstructured":"Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D: Guidelines on myocardial revascularization. Eur Heart J. 2010, 31: 2501-2555.","journal-title":"Eur Heart J"},{"issue":"113","key":"1566_CR9","first-page":"e166","volume":"2006","author":"SC Smith Jr","year":"2001","unstructured":"Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, Morrison DA, O'Neil WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B: e166. Circulation. 2001, 2006 (113): e166-e286.","journal-title":"Circulation"},{"key":"1566_CR10","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","volume":"115","author":"DE Cutlip","year":"2007","unstructured":"Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW: Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007, 115: 2344-2351. 10.1161\/CIRCULATIONAHA.106.685313.","journal-title":"Circulation"},{"key":"1566_CR11","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","volume":"60","author":"K Thygesen","year":"2012","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD: Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012, 60: 1581-1598. 10.1016\/j.jacc.2012.08.001.","journal-title":"J Am Coll Cardiol"},{"key":"1566_CR12","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/j.jacc.2011.01.036","volume":"57","author":"GG Stefanini","year":"2011","unstructured":"Stefanini GG, Serruys PW, Silber S, Khattab AA, van Geuns RJ, Richardt G, Buszman PE, Kelbaek H, van Boven AJ, Hofma SH, Linke A, Klauss V, Wijns W, Macaya C, Garot P, Di Mario C, Manoharan G, Kornowski R, Ischinger T, Bartorelli AL, Gobbens P, Windecker S: The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention). J Am Coll Cardiol. 2011, 57: 2221-2232. 10.1016\/j.jacc.2011.01.036.","journal-title":"J Am Coll Cardiol"},{"key":"1566_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-015-8358-9","volume-title":"Quantitative coronary angiography in clinical practice","author":"PFD Serruys","year":"1994","unstructured":"Serruys PFD, De Feyter PJ: Quantitative coronary angiography in clinical practice. 1994, Dordrecht, The Netherlands: Springer"},{"key":"1566_CR14","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/j.jacc.2011.03.005","volume":"57","author":"AC Yeung","year":"2011","unstructured":"Yeung AC, Leon MB, Jain A, Tolleson TR, Spriggs DJ, Mc Laurin BT, Popma JJ, Fitzgerald PJ, Cutlip DE, Massaro JM, Mauri L: Clinical evaluation of the Resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: the RESOLUTE US clinical trial. J Am Coll Cardiol. 2011, 57: 1778-1783. 10.1016\/j.jacc.2011.03.005.","journal-title":"J Am Coll Cardiol"},{"key":"1566_CR15","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1161\/01.CIR.97.24.2396","volume":"97","author":"A Kastrati","year":"1998","unstructured":"Kastrati A, Schomig A, Elezi S, Schuhlen H, Wilhelm M, Dirschinger J: Interlesion dependence of the risk for restenosis in patients with coronary stent placement in in multiple lesions. Circulation. 1998, 97: 2396-2401. 10.1161\/01.CIR.97.24.2396.","journal-title":"Circulation"},{"key":"1566_CR16","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1001\/jama.299.16.1903","volume":"299","author":"GW Stone","year":"2008","unstructured":"Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Mahaffey KW, Cutlip DE, Fitzgerald PJ, Sood P, Su X, Lansky AJ: Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA. 2008, 299: 1903-1913. 10.1001\/jama.299.16.1903.","journal-title":"JAMA"},{"key":"1566_CR17","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1056\/NEJMoa067193","volume":"356","author":"GW Stone","year":"2007","unstructured":"Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB: Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007, 356: 998-1008. 10.1056\/NEJMoa067193.","journal-title":"N Engl J Med"},{"key":"1566_CR18","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0140-6736(09)60319-6","volume":"373","author":"TA Trikalinos","year":"2009","unstructured":"Trikalinos TA, Alsheikh-Ali AA, Tatsioni A, Nallamothu BK, Kent DM: Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis. Lancet. 2009, 373: 911-918. 10.1016\/S0140-6736(09)60319-6.","journal-title":"Lancet"},{"key":"1566_CR19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s00059-011-3458-z","volume":"36","author":"I Akin","year":"2011","unstructured":"Akin I, Schneider H, Ince H, Kische S, Rehders TC, Chatterjee T, Nienaber CA: Second- and third-generation drug-eluting coronary stents: progress and safety. Herz. 2011, 36: 190-196. 10.1007\/s00059-011-3458-z.","journal-title":"Herz"},{"key":"1566_CR20","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/S0140-6736(11)61672-3","volume":"378","author":"GG Stefanini","year":"2011","unstructured":"Stefanini GG, Kalesan B, Serruys PW, Heg D, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Wijns W, Morice MC, Di Mario C, Corti R, Antoni D, Sohn HY, Eerdmans P, van Es GA, Meier B, Windecker S, Juni P: Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial. Lancet. 2011, 378: 1940-1948. 10.1016\/S0140-6736(11)61672-3.","journal-title":"Lancet"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-14-398.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:15:51Z","timestamp":1630548951000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-14-398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,20]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1566"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-14-398","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,20]]},"assertion":[{"value":"27 May 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"398"}}